NCT05454189

Brief Summary

Implanted port devices (IPD) play an essential role in the safe administration of cancer treatments by providing a device to safely administer caustic chemotherapy agents. The current recommended frequency of flushing the IPD per manufacturers guidelines is every 4-6 weeks. The purpose of this study is to find out if extending IPD flushes to every 12 weeks is safe and if it is just as effective as every 4 week flushing.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
400

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Oct 2022

Typical duration for not_applicable

Geographic Reach
1 country

17 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 24, 2022

Completed
18 days until next milestone

First Posted

Study publicly available on registry

July 12, 2022

Completed
3 months until next milestone

Study Start

First participant enrolled

October 11, 2022

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2025

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

July 2, 2025

Status Verified

June 1, 2025

Enrollment Period

2.7 years

First QC Date

June 24, 2022

Last Update Submit

June 30, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Rate of IPD patency

    IPD patency without major complication

    12 weeks post randomization

Secondary Outcomes (5)

  • Long-term rate of IPD patency in scheduled 4-week versus 12-week IPD flushes at 24,36 and 48 weeks post randomization.

    Up to 48 weeks post randomization

  • Difference in complication rates in scheduled 4-week versus 12-week IPD flushes at 12, 24,36 and 48 weeks post randomization.

    Up to 48 weeks post randomization

  • Difference in healthcare and patient cost in scheduled 4-week versus 12-week IPD flushes

    Up to 48 weeks post randomization

  • Change in Participant Quality of Life and Satisfaction in Scheduled 4-week versus 12 week IPD flushes

    Up to 48 weeks post randomization

  • Impact of smoking, participant age, IPD age, and concomitant medications on complication rates in scheduled 4-week versus 12 week IPD flushes.

    Up to 48 weeks post randomization

Study Arms (2)

4-week IPD Flushing Schedule

ACTIVE COMPARATOR

IPD standard maintenance flushes and port assessments every 4 weeks.

Device: Standard IPD Flush Schedule

12-week IPD Flushing Schedule

EXPERIMENTAL

IPD standard maintenance flushes and port assessments every 12 weeks.

Device: Reduced IPD Flush Schedule

Interventions

IPD flush every 12 weeks

12-week IPD Flushing Schedule

IPD flush every 4 weeks

4-week IPD Flushing Schedule

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Hematology/Oncology patients ≥ 18 years old with an Implanted Port Device.
  • No planned clinical visits for at least 12 weeks.
  • No planned need to access Implanted Port Device within next 12 weeks outside of routine flushing. Potential reasons to access can include but are not limited to lab draw, infusion, IV contrast.
  • No planned removal of IPD within 12 weeks of registration.
  • No Deep Vein Thrombosis or significant Implanted Port Device complication within ≤ 4 weeks of registration.
  • Patient Implanted Port Device with documented blood return ≤ 14 days of registration.
  • Ability to read and speak English.
  • Able to give informed consent.

You may not qualify if:

  • Allergy to heparin
  • Vulnerable populations: pregnant women, prisoners, mentally handicapped.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (17)

Mayo Clinic Health System - Albert Lea

Albert Lea, Minnesota, 56007, United States

RECRUITING

Essentia Health St. Joseph's Medical Center

Brainerd, Minnesota, 56401, United States

RECRUITING

Essentia Health Deer River Clinic

Deer River, Minnesota, 56636, United States

RECRUITING

Essentia Health St Mary's Detroit Lakes Clinic

Detroit Lakes, Minnesota, 56501, United States

RECRUITING

Essentia Health Duluth Clinic

Duluth, Minnesota, 55805, United States

RECRUITING

Essentia Health Fosston

Fosston, Minnesota, 56542, United States

RECRUITING

Fairview Grand Itasca Clinic & Hospital

Grand Rapids, Minnesota, 55744, United States

RECRUITING

Essentia Health Hibbing Clinic

Hibbing, Minnesota, 55746, United States

RECRUITING

Fairview Range Medical Center

Hibbing, Minnesota, 55746, United States

RECRUITING

Mayo Clinic Health System - Mankato

Mankato, Minnesota, 56001, United States

RECRUITING

Monticello Cancer center

Monticello, Minnesota, 55362, United States

RECRUITING

Essentia Health Park Rapids

Park Rapids, Minnesota, 56470, United States

RECRUITING

Fairview Northland Medical Center

Princeton, Minnesota, 55371, United States

RECRUITING

Essentia Health Sandstone

Sandstone, Minnesota, 55072, United States

RECRUITING

Essentia Health Virginia Clinic

Virginia, Minnesota, 55792, United States

RECRUITING

Sanford Worthington Medical Center

Worthington, Minnesota, 56187, United States

RECRUITING

Essentia Health Fargo

Fargo, North Dakota, 58103, United States

RECRUITING

Study Officials

  • Bret Friday, MD, PhD

    Essentia Health

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Model Details: The study is a prospective, randomized study to determine the non-inferiority of every 12 week IPD flushes compared to every 4 week flushes in participants on an IPD maintenance flush schedule.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 24, 2022

First Posted

July 12, 2022

Study Start

October 11, 2022

Primary Completion

July 1, 2025

Study Completion

December 31, 2025

Last Updated

July 2, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will share

The study protocol, statistical plan and consent form will be available on request. Data will be available on aggregate level; data will be deidentified, the full dataset and statistical code will be available upon request

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
6 months after study completion and for 36 months
Access Criteria
A full description of the intended use of the data must be sent to the Project Direct for review and approval. Participant consent for data sharing is conditioned and new ethics approval may be required.

Locations